3+
Notifications
SYSTEM
Notification Number One
×
APPROVAL
Notification Number Two
×
SYSTEM
Notification Number Three
×
Show All Notifications
James Percy
Profile
Settings
Activity Log
Logout
Home
Approval Request
Country
Product
Competition
Reports
Launch Tracker
Admin
Change User To:
User 1
User 2
User 3
User 4
User 5
User 6
User 7
User 8
User 9
User 10
User 11
User 12
User 13
User 14
User 15
User 16
User 17
User 18 (with longer definition to see what happens)
Report: Approval Request List
Filters
Submission Date From:
Submission Date To:
Approval Date From:
Approval Date To:
Status:
All
Draft
Recall
Approval in progress
Approved
Rejected
Effective
Region:
All
International - MENA
International - LATAM
International - AUS and S.Korea
International - Europe North
International - Europe South
International - Canada
International - CEE
International - Baltics
International - Germany
International - APAC
International - UK-IE
International - Italy
International - SP-PT
International - Russia
Japan - Japan
US - US
Country:
Belgium
Croatia
Greece
Netherlands
Spain
United Kingdom
Product:
All
Soliris
Ultomiris
Kanuma
Strensiq
SKU:
Kanuma 1 Vial 30 ml 20 mg
Soliris 1 Vial 30 ml 300 mg
Strensiq 1 Vial 0.3 ml 12 mg
Strensiq 1 Vial 0.45ml 18 mg
Strensiq 1 Vial 0.7 ml 28 mg
Strensiq 1 Vial 0.8 ml 80 mg
Strensiq 1 Vial 1 ml 40 mg
Ultomiris 1 Vial 30 ml 300 mg
Indication:
PNH
aHUS
gMG
NMOSD
LAL-D
HPP
Channel:
Retail
Hospital
Hospital (Out-Patient)
Hospital (In-Patient)
Early Access Program
Retail
Hospital
Hospital (Out-Patient)
Hospital (In-Patient)
Specialty Pharmacy
Physician Office
Source of funding:
All
Public
Private
Individual Patient Funding (IPF)
Early Access Program
Public
Private – Commercial
Public - Medicaid
Public - Medicare
Public - FSS – Big 4
Public - FSS – OGA
Public - PHS/340B
Kaiser
No discount at payer level
Request Type:
All
Mandatory Change
Pricing and Access Renegotiation
Launch Submission
Early Access Program
Individual Patient Funding
Other
Agreement Types:
Simple Discount
Outcome-based Agreement
Risk-Sharing
Indication-based Pricing
CAP (Patient or Revenue)
Price Volume Agreement
Subscription-based Pricing
Other
Apply Filters
Clear
Set as Default
Show/Hide Filters
Approval Requests
Create New Request
Export to Excel
Approval ID
Country
Product
Indication
SKU
Channel
Source of Funding
Request Type
Agreement Type
Status
Submission Date
Approval Date
Last Modified
Last Approver
0001
A Country
A Product
Indications
SKUs
Channel
Source of Funding
Request Type
Agreement Type
Status
2020/04/01
2020/04/01
2020/04/01
Firstname Lastname
0002
B Country
B Product
Indications
SKUs
Channel
Source of Funding
Request Type
Agreement Type
Status
2020/04/03
2020/04/03
2020/04/03
Firstname Lastname
0003
B Country
B Product
Indications
SKUs
Channel
Source of Funding
Request Type
Agreement Type
Status
2020/04/05
2020/04/05
2020/04/05
Firstname Lastname
Add Row(s) - NOT IN USE
Reimbursement Mechanism:
Select...
Public
Private
Channel:
All
Retail
Hospital
Hospital (Out-Patient)
Hospital (In-Patient)
Early Access Program
Retail
Hospital
Hospital (Out-Patient)
Hospital (In-Patient)
Specialty Pharmacy
Physician Office
Indication:
All
PNH
aHUS
gMG
NMOSD
LAL-D
HPP
Add/Edit Country Rule
Country Rule:
Ready to Leave?
×
Select "Logout" below if you are ready to end your current session.